Select Medical (NYSE:SEM) Releases FY 2024 Earnings Guidance

Select Medical (NYSE:SEM) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided EPS guidance of 1.960-2.200 for the period, compared to the consensus EPS estimate of 2.030. The company issued revenue guidance of $6.9 billion-$7.1 billion, compared to the consensus revenue estimate of $7.0 billion.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on SEM. Benchmark reaffirmed a buy rating and set a $39.00 price objective on shares of Select Medical in a report on Friday. StockNews.com upgraded Select Medical from a hold rating to a buy rating in a research report on Friday, March 22nd. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Select Medical has a consensus rating of Moderate Buy and a consensus price target of $34.40.

Select Medical Stock Up 10.5 %

SEM opened at $31.43 on Monday. The company has a debt-to-equity ratio of 2.30, a current ratio of 1.22 and a quick ratio of 1.22. Select Medical has a one year low of $21.28 and a one year high of $33.51. The firm has a market capitalization of $4.09 billion, a P/E ratio of 14.97, a price-to-earnings-growth ratio of 1.24 and a beta of 1.38. The company has a fifty day moving average price of $28.42 and a 200-day moving average price of $25.95.

Select Medical (NYSE:SEM) last released its earnings results on Friday, February 23rd. The health services provider reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Select Medical had a return on equity of 18.11% and a net margin of 3.97%. The business had revenue of $1.66 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the prior year, the firm earned $0.22 earnings per share. The firm’s revenue was up 4.9% on a year-over-year basis. Equities research analysts expect that Select Medical will post 2.03 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 30th. Shareholders of record on Thursday, May 16th will be paid a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 1.59%. The ex-dividend date of this dividend is Wednesday, May 15th. Select Medical’s dividend payout ratio (DPR) is presently 23.81%.

Insider Transactions at Select Medical

In other news, Chairman Robert A. Ortenzio sold 50,000 shares of Select Medical stock in a transaction that occurred on Monday, April 8th. The stock was sold at an average price of $29.90, for a total value of $1,495,000.00. Following the sale, the chairman now directly owns 6,689,668 shares in the company, valued at approximately $200,021,073.20. The sale was disclosed in a filing with the SEC, which is available through this link. 17.50% of the stock is currently owned by company insiders.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.